The study, conducted by Elissa Ozanne, PhD, at Dartmouth found that 11 of the 15 women, aged 45-79 years, interviewed before and after using the mHealth tool preferred it to a paper tool and found it easy to use.
Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD, from Dartmouth's Norris Cotton Cancer Center and colleagues concluded that older, diverse, and low income women found it easy to use and acceptable. Published in the Journal of Health Disparities Research Practices, the paper with these findings is "Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women."
"Studies such as this are critical to understand how mHealth tools can be used effectively in diverse, low-income populations," said Ozanne. "We need to design all tools, and particularly novel tools such as mHealth tools, with these populations in mind in order to ensure equitable access. This study identifies some of the barriers and benefits of using an mHealth tool in this low-income, diverse population."
Link to the news release by Dartmouth: http://bit.ly/1x8u2Fv
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen